Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhubei Dingchuan Pills is a traditional Chinese medicine (TCM) developed and manufactured by Jiangxi Wannianqing Pharmaceutical. It is formulated as an oral pill primarily indicated for the treatment of bronchial asthma and chronic bronchitis. The preparation is a complex mixture of herbal and mineral ingredients, including *Margarita* (Pearl), *Bulbus Fritillariae Cirrhosae* (Chuanbeimu), *Flos Daturae* (Yangjinhua), and *Radix Glycyrrhizae* (Licorice). Its therapeutic action is characterized by clearing heat, resolving phlegm, and suppressing cough and asthma. Mechanistically, it provides bronchodilation through the anticholinergic activity of alkaloids found in *Flos Daturae* and *Fritillaria*, while other components contribute anti-inflammatory and expectorant properties to alleviate chronic airway obstruction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhubei dingchuan pills.